JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 136 EUR | -1.97% |
|
0.00% | -12.66% |
| 01:00pm | New semester, new state of mind |  |
| 28/06 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | Other Pharmaceuticals | +1.86% | 0.00% | -12.66% | -17.86% | - | 35TCr | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- Charts Johnson & Johnson
- Comparison Chart
